Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-24T21:47:40.596Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Pulsed-Field Gel Electrophoresis for a Pseudoepidemic of Clostridium difficile Infections in a Pediatric Oncology and Hematology Department

Published online by Cambridge University Press:  02 January 2015

Celine Hernandez ,
Olivier Meunier ,
Frederique Audeoud ,
Patrick Lutz  and
Michel Bientz
Celine Hernandez
Affiliation:
Strasbourg Institute of Health, France
Olivier Meunier
Affiliation:
Strasbourg Institute of Health, France
Frederique Audeoud
Affiliation:
Paediatric Oncology and Haematology Department, Strasbourg University Hospitals, France
Patrick Lutz
Affiliation:
Paediatric Oncology and Haematology Department, Strasbourg University Hospitals, France
Michel Bientz
Affiliation:
Strasbourg Institute of Health Strasbourg, France
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 9 , September 2004 , pp. 708 - 709
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

References

1.Wehl, G, Allerberger, F, Heitger, A, Meister, B, Maurer K, Fink, FM. Trends in infection morbidity in a pediatric oncology ward, 1986-1995. Med Pediatr Oncol 1999;32:336–343.Google Scholar
2.Schuller, I, Saha, V, Lin, L, Kingston, J, Eden, T, Tabaqchali, S. Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 1995;72:219–222.CrossRefGoogle Scholar
3.Gorschlüter, M, Glasmacher, A, Hahn, C, et al.Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001;33: 786–791.CrossRefGoogle ScholarPubMed
4.Kyne, L, Warny, M, Qamar, A, Kelly, CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390–397.Google Scholar
5.Kyne, L, Warny, M, Qamar, A, Kelly, CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357:189–193.CrossRefGoogle ScholarPubMed
6.Gerard, M, Defesne, N, Daneau, D, et al.Incidence and significance of Clostridium difficile in hospitalized cancer patients. Eur J Clin Microbiol Infect Dis 1988;7:274–278.Google Scholar
7.Lemann, F, Chambon, C, Barbut, F, et al.Arbitrary primed PCR rules out Clostridium difficile cross-infection among patients in a haematology unit. J Hosp Infect 1997;35:107–115.Google Scholar
8.Rojas, S, Cohen, H, Tang, VJ, Wilson, J, Inciardi, J, Silva, J Jr.Differing epidemiology of Clostridium difficile-associated diarrhea between an oncology ward and a general medicine ward. Infect Control Hosp Epidemiol 1999;20:14–15.Google Scholar
9.Brazier, JS. Typing of Clostridium difficile. Clin Microbiol Infect 2001;7:428–431.Google Scholar
10.Shim, JK, Johnson, S, Samore, MH, Bliss, DZ, Gerding, DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998;351:633–636.Google Scholar